Cornerstone Capital Management Holdings’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.97M Sell
60,900
-4,300
-7% -$129K 0.01% 764
2017
Q3
$2.03M Buy
65,200
+3,900
+6% +$115K 0.02% 741
2017
Q2
$1.71M Buy
61,300
+49,800
+433% +$1.13M 0.01% 775
2017
Q1
$196K Buy
11,500
+6,000
+109% +$84K ﹤0.01% 1171
2016
Q4
$66K Buy
+5,500
New +$71.2K ﹤0.01% 1263
2016
Q1
Sell
-7,300
Closed -$164K 1585
2015
Q4
$164K Buy
7,300
+2,300
+46% +$45.5K ﹤0.01% 1242
2015
Q3
$117K Buy
+5,000
New +$138K ﹤0.01% 1314

Other funds holding XENT

Cornerstone Capital Management Holdings's XENT Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Intersect ENT, Inc (XENT) stake by 6.6% in Q4 2017, selling an estimated $129K and leaving 60,900 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #764.

Cornerstone Capital Management Holdings first reported a position in XENT in Q3 2015 and has held it in 7 quarters since. The position peaked at $2.03M in Q3 2017. 157 funds tracked by Wall St. Rank hold XENT as of Q4 2017.

  • Cornerstone Capital Management Holdings held 60,900 shares of Intersect ENT, Inc worth $1.97M as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 4,300 Intersect ENT, Inc shares in Q4 2017, an estimated $129K.
  • Intersect ENT, Inc made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #764 holding.
  • Cornerstone Capital Management Holdings first reported a position in Intersect ENT, Inc in Q3 2015 and has held it in 7 quarters since.
  • Cornerstone Capital Management Holdings's Intersect ENT, Inc position peaked at $2.03M in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.